This industry includes cell biology, tissue engineering, agricultural specialist, food processing chemist, and geneticist (i.e. specializing in stem cell or gene therapy, etc.). Many of the technologies brought forth by this industry are a combination of existing Pharmaceutical or Medical Device companies, or are the result of the formation of a new division or company.

This sector is growing at a rate of 35-40% annually and is currently valued as a $2 billion market. As an emerging field, it has a projected market cap of $50 billion in years to come.

Some of the major companies in this field include: Amgen, Biogen, Genentech, Genzyme, Immunes, and Centocor.